Atoyebi, S. A., Rajoli, R. K., Adejuyigbe, E., Owen, A., Bolaji, O., Siccardi, M., & Olagunju, A. (2019). Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies. Eur J Pharm Sci.
Chicago Style CitationAtoyebi, Shakir Adeyinka, Rajith K.R Rajoli, Ebunoluwa Adejuyigbe, Andrew Owen, Oluseye Bolaji, Marco Siccardi, i Adeniyi Olagunju. "Using Mechanistic Physiologically-based Pharmacokinetic Models to Assess Prenatal Drug Exposure: Thalidomide Versus Efavirenz As Case Studies." Eur J Pharm Sci 2019.
Cita MLAAtoyebi, Shakir Adeyinka, et al. "Using Mechanistic Physiologically-based Pharmacokinetic Models to Assess Prenatal Drug Exposure: Thalidomide Versus Efavirenz As Case Studies." Eur J Pharm Sci 2019.